Akèy › Skleroz Amiotrofik Lateral › Washington › Seattle
Etid klinik pou Skleroz Amiotrofik Lateral nan Seattle, WA
7 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Ap rekriteFaz 3
- Swedish Medical Center, Seattle
- University of Washington, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Seattle Neuropsychiatric Treatment Center, Seattle
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Ap rekriteFaz 2
- Zydus US011, Seattle
ASSESS ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Washington, Seattle
PREVENT ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Washington, Seattle
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Washington, Seattle
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Washington, Seattle
Etid Skleroz Amiotrofik Lateral nan lòt vil
- Boston, MA19 etid
- Philadelphia, PA14 etid
- Baltimore, MD13 etid
- Jacksonville, FL13 etid
- New York City, NY11 etid
- San Diego, CA10 etid
- Chicago, IL10 etid
- San Francisco, CA10 etid
- St. Louis, MO9 etid
- Phoenix, AZ8 etid
- Dallas, TX8 etid
- Atlanta, GA8 etid
Lòt etid nan Seattle
- Kansè Poumon ki pa ti selil53 etid
- Kansè (tout kalite)49 etid
- Kansè pwostat42 etid
- Leksemi mieloïd egi40 etid
- Kansè nan tete39 etid
- Kansè Metastatik39 etid
- Kansè kolorektal34 etid
- Kansè poumon33 etid
- Kansè ovè30 etid
- Myelom Miltip22 etid
- Sendwòm myelodisplastik21 etid
- Leksemi limfoblastik egi21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.